Company / Return on Equity (ROE)
KIORA PHARMACEUTICALS INC Return on Equity (ROE) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
14.0%
FY2025
5-year range
-204.8% / 14.0%
FY2021-FY2025
Trend
+106.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Equity (ROE) returned to growth in FY2025 after 2 years of decline, reaching 14.0%.
Based on SEC 10-K filings.
14.0% in FY2025 with a 5-year CAGR of +121.1%.
Improved from -122.2% to 14.0% over the past 4 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- +121.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 106.8% year-over-year.
- Lowest return on equity (roe) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 14.0% | +106.8% |
| FY2024 | -204.8% | -67.6% |
| FY2021 | -122.2% | -14.0% |
| FY2020 | -107.2% | +11.4% |
| FY2019 | -121.0% | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026